ARTICLE | Company News
Genentech wins GSK patent suit
May 4, 2001 7:00 AM UTC
A jury in the U.S. District Court for the District of Delaware unanimously found that DNA's products, Herceptin trastuzumab for breast cancer and Rituxan rituximab for non-Hodgkin's lymphoma (NHL), do...